BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Nosology
,
Doxycycline
,
rs7903146
,
GATA1
,
Metabolism of xenobiotics
,
Influenza
,
Embryo
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
proptosis
(phenotype)
Summary
General Info
Genetic Markers
Most Correlated Genes
Most Correlated SNPs
PDGFRB
No SNPs found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
metanephric mesenchymal cell migration
Platelet-derived growth factor receptor beta
cell migration involved in kidney development
positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway
positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
OMIM - Kosaki overgrowth syndrome
Explore Curated Studies Results
Literature
Most Relevant Literature
Proptosis Regression After Teprotumumab Treatment for Thyroid Eye Disease.
A comparison of proptosis reduction with teprotumumab versus surgical decompression based on fat-to-…
Teprotumumab and Orbital Decompression for the Management of Proptosis in Patients With Thyroid Eye …
Exophthalmos associated with chronic progressive external ophthalmoplegia.
Re: "Proptosis Regression After Teprotumumab Treatment for Thyroid Eye Disease".
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Treatment of Graves' Orbitopathy to Reduce Proptosis With Teprotumumab Infusions in an Open-Label Cl…
Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusio…
Extension Study to Assess Batoclimab in Participants With Thyroid Eye Disease
Local Betamethasone Versus Triamcinolone Injection in Management of Thyroid Eye Disease
Reliability of Hertel Exophthalmometer Measurements
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ